Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (911-920 of 1,095) with videos related to

Pageof 110
Sort By:
Cancer Immunology, Immunotherapy : CII|October 2, 2024
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapyAndrea De Giglio, Alessandro Leonetti, Francesca Comito, et al.
Epilepsia|July 20, 2007
Mutational analysis of EFHC1 gene in Italian families with juvenile myoclonic epilepsyFerdinanda Annesi, Antonio Gambardella, Roberto Michelucci, et al.
The Oncologist|October 5, 2023
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort StudyFederica Pecci, Luca Cantini, Valeria Cognigni, et al.
Journal of Hepatology|October 11, 2015
Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infectionStefan Zeuzem, Christophe Hézode, Jean-Pierre Bronowicki, et al.
Gastroenterologia Y Hepatologia|February 2, 2023
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels)Mar Riveiro-Barciela, Luisa Roade, Joan Martínez-Camprecios, et al.
Scientific Reports|March 12, 2026
Clinically interpretable nomogram combining body composition and clinicopathological features for one year survival prediction in advanced solid tumorsGiulia Bruschi, Francesco Paoloni, Federica Pecci, et al.
The American Journal of Gastroenterology|August 10, 2023
Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone SafetyHenry L Y Chan, Maria Buti, Young-Suk Lim, et al.
Kidney International|October 5, 2024
Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressantsValentina Raglianti, Maria Lucia Angelotti, Luigi Cirillo, et al.
Future Oncology (London, England)|April 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
The control of prickle formation in <i>Rubus</i>Brian St Aubin, Tom Poorten, Andrew Fister, et al.
Pageof 110

Showing results (911-920 of 1,095) with videos related to

Sort By:
Pageof 110
Cancer Immunology, Immunotherapy : CII|October 2, 2024
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapyAndrea De Giglio, Alessandro Leonetti, Francesca Comito, et al.
Epilepsia|July 20, 2007
Mutational analysis of EFHC1 gene in Italian families with juvenile myoclonic epilepsyFerdinanda Annesi, Antonio Gambardella, Roberto Michelucci, et al.
The Oncologist|October 5, 2023
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort StudyFederica Pecci, Luca Cantini, Valeria Cognigni, et al.
Journal of Hepatology|October 11, 2015
Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infectionStefan Zeuzem, Christophe Hézode, Jean-Pierre Bronowicki, et al.
Gastroenterologia Y Hepatologia|February 2, 2023
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels)Mar Riveiro-Barciela, Luisa Roade, Joan Martínez-Camprecios, et al.
Scientific Reports|March 12, 2026
Clinically interpretable nomogram combining body composition and clinicopathological features for one year survival prediction in advanced solid tumorsGiulia Bruschi, Francesco Paoloni, Federica Pecci, et al.
The American Journal of Gastroenterology|August 10, 2023
Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone SafetyHenry L Y Chan, Maria Buti, Young-Suk Lim, et al.
Kidney International|October 5, 2024
Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressantsValentina Raglianti, Maria Lucia Angelotti, Luigi Cirillo, et al.
Future Oncology (London, England)|April 29, 2024
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study)Fabio Catalano, Matteo Brunelli, Alessio Signori, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
The control of prickle formation in <i>Rubus</i>Brian St Aubin, Tom Poorten, Andrew Fister, et al.
Pageof 110